Literature DB >> 21713598

Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.

Ravindra Kumar1, Inusha Panigrahi, Ashwin Dalal, Sarita Agarwal.   

Abstract

OBJECTIVE: To study the issues and dilemmas in prenatal diagnosis of Sickle cell anemia (SCA) and to evaluate the role of genetic modifiers in counseling the families.
METHODS: The authors studied the genotype in 47 individuals with increased HbS and three representative families were taken as an example for describing various issues which need to be sorted out for appropriate counseling.
RESULTS: Of 47 individuals 24 were S beta thalassemia, 14 were homozygous sickle cell anemia (SS) and 9 were HbS trait. In the S beta thalassemia and homozygous SS cases, anemia was presenting manifestation in all. The transfusion requirement in these varied from 0-12 transfusions/ year. Hepatosplenomegaly was seen in 27 cases (71%) and only splenomegaly in 9 cases (23.7%). Jaundice was observed in 34 cases (84.2%). All the 47 subjects (including HbS trait) were studied by Hb Variant system and underwent DNA analysis for beta globin gene mutations, alpha globin gene number and XmnI polymorphism. One or two alpha gene deletion of 3.7 kb (-α3.7/αα or -α3.7/-α3.7) was found in 11 out of 47 cases whereas alpha triplication was found in 2 cases. 28 cases were heterozygous (+/-) for XmnI polymorphism, 9 were homozygous negative (-/-) and 10 were homozygous positive (+/+). Patients with SCA co-inherited with α-thalassemia have less hemolysis as revealed by lower reticulocyte counts than with normal alpha genotype. The authors further discuss the issues and dilemmas faced during prenatal counseling of three families during this study.
CONCLUSIONS: The knowledge of the relationship between genotype and phenotype, effect of the modifier genes has an important role in genetic counseling and for planning individualized treatment for sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713598     DOI: 10.1007/s12098-011-0510-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

1.  Epidemiology of sickle cell disease in a rural hospital of central India.

Authors:  M Kamble; P Chatruvedi
Journal:  Indian Pediatr       Date:  2000-04       Impact factor: 1.411

2.  Clinical examination and hematological data in asymptomatic & apparently healthy school children in a boarding school in a tribal area.

Authors:  K Ghosh; M B Mukherjee; U Shankar; S L Kote; S B Nagtilak; R B Kolah; R R Surve; A A Tamankar; S Sukumar
Journal:  Indian J Public Health       Date:  2002 Apr-Jun

3.  Spectrum of hemoglobinopathies in Orissa, India.

Authors:  Guru Prasad Chhotray; Bisnu Prasad Dash; Manoranjan Ranjit
Journal:  Hemoglobin       Date:  2004-05       Impact factor: 0.849

Review 4.  Predicting clinical severity in sickle cell anaemia.

Authors:  M H Steinberg
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

5.  Thalassemia intermedia: heterozygous beta-thalassemia and co-inheritance of an a gene triplication.

Authors:  Sarita Agarwal; Swati Sarwai; Savita Agarwal; Usha R Gupta; Shubha Phadke
Journal:  Hemoglobin       Date:  2002-08       Impact factor: 0.849

6.  Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes.

Authors:  M Sutton; E E Bouhassira; R L Nagel
Journal:  Am J Hematol       Date:  1989-09       Impact factor: 10.047

7.  Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.

Authors:  Roshan Colah; Reema Surve; Anita Nadkarni; Ajit Gorakshakar; Supriya Phanasgaonkar; Poornima Satoskar; Dipika Mohanty
Journal:  Prenat Diagn       Date:  2005-05       Impact factor: 3.050

8.  Sickle cell disease among tribes of Andhra Pradesh and Orissa, India.

Authors:  B V Babu; B L Krishna Leela; Y S Kusuma
Journal:  Anthropol Anz       Date:  2002-06

9.  Prenatal diagnosis in beta-thalassemia: an Indian experience.

Authors:  S Agarwal; A Gupta; U R Gupta; S Sarwai; S Phadke; S S Agarwal
Journal:  Fetal Diagn Ther       Date:  2003 Sep-Oct       Impact factor: 2.587

10.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

Authors:  Paul Telfer; Pietro Coen; Subarna Chakravorty; Olu Wilkey; Jane Evans; Heather Newell; Beverley Smalling; Roger Amos; Adrian Stephens; David Rogers; Fenella Kirkham
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

View more
  5 in total

1.  Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.

Authors:  Tite Minga Mikobi; Prosper Tshilobo Lukusa; Michel Ntetani Aloni; Aimé Lumaka; Pierre Zalagile Akilimali; Koenraad Devriendt; Gert Matthijs; Jean-Marie Mbuyi Muamba; Valerie Race
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

2.  Situational Analysis of Sickle Cell Disease in Gujarat, India.

Authors:  Deepak Saxena; Sandul Yasobant; Mahaveer Golechha
Journal:  Indian J Community Med       Date:  2017 Oct-Dec

3.  Morbidity pattern of sickle cell disease in India: a single centre perspective.

Authors:  Sanjay Tewari; David Rees
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

4.  Sickle cell disease in India: A perspective.

Authors:  Graham R Serjeant; Kanjaksha Ghosh; Jyotish Patel
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

5.  Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.

Authors:  Paul Telfer; Irene Agodoa; Kathleen M Fox; Laurie Burke; Timothy Mant; Marzena Jurek; Margaret Tonda; Josh Lehrer-Graiwer
Journal:  Hematol Rep       Date:  2018-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.